Biomarkers in the Diagnosis of Endometrial Precancers. Molecular Characteristics, Candidate Immunohistochemical Markers, and Promising Results of Three-Marker Panel: Current Status and Future Directions

Shuang Niu,Kyle Molberg,Diego H. Castrillon,Elena Lucas,Hao Chen

DOI: https://doi.org/10.3390/cancers16061159

2024-03-16

Cancers

Abstract:Endometrial carcinoma stands as the most prevalent gynecological cancer and the fourth most common cancer affecting women. The incidence of endometrial cancer has been steadily increasing over the past decade, posing a significant threat to public health. The early detection of its precancers remains a critical and evolving concern to reduce mortality associated with endometrial carcinoma. In the last decade, our understanding of endometrial carcinoma and its precancers has advanced through systematic investigations into the molecular genetics of endometrial carcinoma and its precancers. In this review, we focus on advances in precancers associated with the endometrioid subtype, by far the most common histologic variant of endometrial adenocarcinoma. Recent investigations have led to the identification of new biomarkers, and the proposed incorporation of these biomarkers or biomarker panels into the diagnostic framework of endometrial carcinoma precancers. Here, we review these recent advances and their relevance to the histopathologic diagnosis of endometrial carcinoma precancers.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to improve the diagnostic accuracy of endometrial precancerous lesions (i.e., endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia, abbreviated as AH/EIN). Specifically, the paper explores the application value of new biomarkers and their combinations (especially the three - biomarker combination) discovered through molecular genetics research in the diagnosis of AH/EIN, aiming to provide more accurate diagnostic tools for the clinic, thereby detecting these precancerous lesions early and reducing the incidence and mortality of endometrial cancer.

The paper emphasizes the following key points:
1. **Epidemiological characteristics of endometrial cancer**: Endometrial cancer is one of the most common gynecological cancers in women. Its incidence has been continuously rising in the past decade, becoming an important threat to public health.
2. **Importance of precancerous lesions**: Early detection of endometrial precancerous lesions is crucial for preventing cancer progression and can significantly reduce cancer - related mortality.
3. **Advances in molecular genetics**: In recent years, important progress has been made in molecular genetics research on endometrial cancer and its precancerous lesions, especially in the research on the most common type of endometrial cancer - endometrioid adenocarcinoma (endometrioid subtype).
4. **Discovery of new biomarkers**: The research has discovered multiple potential biomarkers, which can help to identify precancerous lesions more accurately and improve the accuracy and reliability of diagnosis.
5. **Application of the three - biomarker combination**: The paper pays special attention to the application of a combination consisting of three biomarkers in the diagnosis of AH/EIN, demonstrating its potential in improving diagnostic accuracy.

Through these studies, the paper aims to provide clinicians with more effective tools to identify and treat endometrial precancerous lesions at an early stage, thereby improving the prognosis of patients.